ACAD

ACADIA Pharmaceuticals develops and sells medicines for brain and nervous system disorders, particularly focusing on rare diseases. The company's main approved drug is Nuplazid, which treats hallucinations and delusions in people with Parkinson's disease, and Daybue, which treats symptoms of Rett syndrome, a rare genetic disorder affecting children. ACADIA also has several experimental drugs in development for conditions like Alzheimer's disease psychosis, depression, and movement disorders. The company is based in San Diego and works with other pharmaceutical companies through licensing agree…